8-K filed Feb 25, 2026 at 16:54 ET
LeMaitre Vascular (LMAT) reported strong Q4 2025 results with revenue of $64.5 million (+16% YoY) and diluted EPS of $0.68 (+39% YoY), driven by international growth and margin expansion. The company raised its quarterly dividend by 25% to $0.25/share and authorized a $100 million share repurchase program. Full-year 2026 guidance calls for $280 million in sales (+12%) and operating income of $77.8 million (+21% adjusted), signaling continued profitability growth.